Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 32.28% vs 2.08% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 1,463.67% vs 76.41% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 779.72% vs 265.29% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -33.33% vs 0.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Wakamoto Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 32.28% vs 2.08% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 46.71% vs 1.42% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 1,463.67% vs 76.41% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 184.75% vs 608.67% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 779.72% vs 265.29% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 979.48% vs -73.45% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is -33.33% vs 0.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 100.00% vs 0.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






